Clinical Trial Update: Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity and reactogenicity of various formulations of recombinant hepatitis B vaccine conducted by GlaxoSmithKline; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED